hiv-1 zinc fingers: a target for rational drug development.

NLM AIDSLINE HIV-1 zinc fingers: a target for rational drug development. Arthur L; Rice W; Turpin J; Rein A; Lifson J; Gorelick R; Ott D; Casas
November 30, 1996

3rd Conf Retro and Opportun Infect. 1996 Jan 28-Feb 1;:178. Unique Nucleocapsid (NC) proteins of retroviruses contain sequences of 14 amino acids with 4 invariant residues, Cys(X)2Cys(X)4His(X)4Cys(CCHC), that chelate zinc through histidine imidazole and cysteine thiolates(K(d)less than 10(3)). The CCHC motif is one of the most highly conserved features in retroviruses and is necessary to package genomic RNA into the virus. Mutants with altered zinc-chelating residues (CCCC and CCHH) package genomic RNA but are still noninfectious; thus the CCHC motif is essential for early infection event(s). This apparent immutability of the CCHC finger makes this structure an ideal drug target. We find that the conserved cysteine thiolates (S) in the finger can be destroyed by electrophilic reagents and retrovirus particles are inactivated by exposure to the reagents. We have developed a screening pathway which begins with identification of lead compounds based on structure and functional groups and extends to demonstration of activity on purified NC protein, reaction with zinc fingers in the intact virus, anti-viral activity in tissue culture, anti-viral activity in a SFFV/murine model and anti-viral activity in SIV-infected macaques. Results of this drug evaluation screen will be discussed. Antiviral Agents/CHEMICAL SYNTHESIS/PHARMACOLOGY Capsid/METABOLISM Chelating Agents HIV-1/DRUG EFFECTS/GENETICS/METABOLISM Human Structure-Activity Relationship Zinc Fingers ABSTRACT

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Photographs from A Day with HIV Now Online Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 CANADA: Health Officials in St. John's N.L., Inform 50 People of Tuberculosis Risk OHIO: Cleveland LGBT Community Center Offers Free Support Groups and HIV, STD Testing: The Frugal Patient CALIFORNIA: Local Church Sends HIV/AIDS Care Packs to Swaziland NEVADA: Clinics Offer Low-Cost Care for those Lacking Insurance CONNECTICUT: At Hartford Public High School, A Day Reserved for 'Healthy Relationships' ITALY: HIV Is No Barrier to Successful Liver Transplant for Cancer Treatment KENYA: Kenya Launches Universal HPV Vaccine Access to Youths UNITED STATES: Navajo Confront an Increase in New H.I.V. Infections Uganda: HIV Vaccine Trials to Start in July Uganda: Remembering Those Killed By HIV/AIDS (International AIDS Candlelight Memorial) OHIO: Cleveland LGBT Community Center Offers Free Support Groups and HIV, STD Testing: The Frugal Patient CALIFORNIA: Local Church Sends HIV/AIDS Care Packs to Swaziland ITALY: HIV Is No Barrier to Successful Liver Transplant for Cancer Treatment UNITED STATES: Navajo Confront an Increase in New H.I.V. Infections Uganda: HIV Vaccine Trials to Start in July Uganda: Remembering Those Killed By HIV/AIDS (International AIDS Candlelight Memorial)Navajo Confront an Increase in New H.I.V. Infections TB, HIV and malaria vaccine research gets major boost Measuring hidden HIV Sangamo BioSciences Presents New Data From In Vivo Protein Replacement Platform For Development Of ZFP Therapeutics® For Monogenic Diseases
Information in this article was accurate in November 30, 1996. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.